Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

3.62
-0.1000-2.69%
Post-market: 3.640.0199+0.55%19:58 EDT
Volume:231.76K
Turnover:842.26K
Market Cap:2.90M
PE:-0.25
High:3.76
Open:3.62
Low:3.53
Close:3.72
Loading ...

Alzamend Neuro announces initiation date of Phase II trial of AL001

TIPRANKS
·
04 Mar

Alzamend Neuro Announces Initiation Date of Phase Ii Clinical Trial of Al001 for Treatment of Bipolar Disorder to Take Place at Massachusetts General Hospital

THOMSON REUTERS
·
04 Mar

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

GlobeNewswire
·
04 Mar

Ambarella Appoints Chantelle Breithaupt as Independent Director

TIPRANKS
·
01 Mar

Alzamend Neuro (ALZN) Gets a Hold from Maxim Group

TIPRANKS
·
27 Feb

Alzamend Neuro Announces Initiation Date of First Phase Ii Clinical Trial of Al001 to Take Place at Massachusetts General Hospital

THOMSON REUTERS
·
25 Feb

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

GlobeNewswire
·
25 Feb

EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025

Benzinga
·
25 Feb

BRIEF-Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital

Reuters
·
19 Feb

Alzamend Neuro announces completion of head coil by Tesla Dynamic Coils

TIPRANKS
·
19 Feb

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase Ii Clinical Trials at Massachusetts General Hospital

THOMSON REUTERS
·
19 Feb

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Business Wire
·
19 Feb

EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels

Benzinga
·
19 Feb

Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?

Zacks
·
23 Jan

Alzamend Neuro to Present at the Sequire Investor Summit

Business Wire
·
15 Jan

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Business Wire
·
18 Dec 2024

Alzamend Neuro Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
16 Dec 2024

Alzamend Neuro says net cash gained by financing activity $8.3M

TIPRANKS
·
12 Dec 2024

Alzamend Neuro Q2 EPS $(0.40) Beats $(0.77) Estimate

Benzinga
·
12 Dec 2024

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

THOMSON REUTERS
·
12 Dec 2024